Surgical Innovations Group plc (SUN.L) LSE
Currency In GBp
- General
- Statistics
- Historical Data
- Profile
- Financials
Currency In GBp
Address
Clayton Wood House
Leeds, LS16 6QZ
United Kingdom of Great Britain and Northern Ireland (the)
Phone
44 11 3230 7597
Website
Sector
Healthcare
Industry
Medical - Devices
Employees
80
First IPO Date
December 08, 1988
| Name | Title | Pay | Year Born |
| David John Marsh | Chief Executive Officer & Director | 224,000 | 1964 |
| Brent Raymond Greetham | Chief Financial Officer, Company Secretary & Director | 0 | 1976 |
| Damian Donnelly | Chief Commercial Officer | 0 | N/A |
| Julia Horrocks Taylor | HR Director | 0 | N/A |
| Stephen Seed | Chief Compliance Officer | 0 | N/A |
Established in 1988 and headquartered in Leeds, United Kingdom, Surgical Innovations Group plc is an international enterprise engaged in the design, development, manufacturing, and marketing of devices for minimally invasive surgery (SI) and precision engineering applications. Its global presence extends across the UK, Europe, the Asia Pacific region, and the United States. The company operates through three distinct divisions: SI Brand, Original Equipment Manufacturer (OEM), and Distribution. The SI Brand segment is responsible for the research, development, production, and commercialization of its proprietary SI-branded minimally invasive instruments. Key products within this portfolio include the YelloPort Elite and YelloPort +plus laparoscopic port access systems, LogiRange resposable laparoscopic instrument systems, FastClamp laparoscopic clamping systems, and QuickRange single-use laparoscopic instrumentation. The OEM division focuses on crafting and supplying minimally invasive devices for third-party medical device firms, often under their own brand or through co-branding arrangements. This segment also provides comprehensive design and development solutions for creating final medical devices and is involved in the research, development, manufacturing, and sale of minimally invasive technology tailored for precision engineering. Lastly, the Distribution segment handles the supply of various medical products, primarily via its subsidiary, Elemental Healthcare Ltd, and also designs and produces autologous blood products. Surgical Innovations Group plc sells its offerings through a network of independent healthcare distributors, while its own-label products are also distributed through its OEM collaborations.